<DOC>
	<DOCNO>NCT01509027</DOCNO>
	<brief_summary>Hyperphosphatemia common severe complication chronic kidney disease patient treat hemodialysis . A phosphate restrict diet oral phosphate binder cornerstones prevention treatment complication . However , noncompliance prevalent problem result poorly control hyperphosphatemia substantial proportion hemodialysis patient . The present study aim identify risk factor non compliance also test hypothesis compliance improved education patient consequence hyperphosphatemia importance diet phosphate binder therapy .</brief_summary>
	<brief_title>Study Compliance With Phosphorus Restricted Diet Phosphate Binder Therapy Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>prevalent ( &gt; 3months ) hemodialysis patient age &gt; 18 year informed consent decrease consciousness unstable medical contraindication phosphorus restrict diet phsophate binder therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>hyperphoshatemia</keyword>
	<keyword>compliance</keyword>
</DOC>